A detailed history of Prelude Capital Management, LLC transactions in Si Bone, Inc. stock. As of the latest transaction made, Prelude Capital Management, LLC holds 11,923 shares of SIBN stock, worth $154,999. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,923
Holding current value
$154,999
% of portfolio
0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$15.15 - $21.58 $180,633 - $257,298
11,923 New
11,923 $195,000
Q1 2023

May 15, 2023

BUY
$12.71 - $21.17 $128,485 - $214,007
10,109 New
10,109 $198,000
Q3 2022

Nov 14, 2022

SELL
$12.2 - $18.71 $104,590 - $160,400
-8,573 Reduced 18.86%
36,879 $644,000
Q2 2022

Aug 15, 2022

SELL
$12.05 - $22.74 $45,392 - $85,661
-3,767 Reduced 7.65%
45,452 $600,000
Q1 2022

May 16, 2022

SELL
$18.32 - $23.03 $206,667 - $259,801
-11,281 Reduced 18.65%
49,219 $1.11 Million
Q4 2021

Feb 14, 2022

BUY
$18.75 - $24.8 $225,000 - $297,600
12,000 Added 24.74%
60,500 $1.34 Million
Q3 2021

Nov 15, 2021

BUY
$19.65 - $31.89 $471,599 - $765,360
24,000 Added 97.96%
48,500 $1.04 Million
Q2 2021

Aug 16, 2021

BUY
$29.4 - $35.96 $720,300 - $881,020
24,500 New
24,500 $771,000
Q3 2020

Nov 16, 2020

SELL
$15.68 - $24.28 $12,544 - $19,424
-800 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$10.56 - $18.46 $3,168 - $5,538
-300 Reduced 27.27%
800 $13,000
Q1 2020

May 15, 2020

BUY
$8.36 - $22.67 $2,508 - $6,801
300 Added 37.5%
1,100 $13,000
Q4 2019

Feb 14, 2020

BUY
$15.73 - $21.81 $12,584 - $17,448
800 New
800 $17,000
Q3 2019

Nov 14, 2019

SELL
$17.15 - $20.26 $21,986 - $25,973
-1,282 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$15.13 - $20.34 $19,396 - $26,075
1,282 New
1,282 $26,000

Others Institutions Holding SIBN

About SI-BONE, Inc.


  • Ticker SIBN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 34,305,000
  • Market Cap $446M
  • Description
  • SI-BONE, Inc., a medical device company, develops implantable devices used to solve musculoskeletal disorders of the sacropelvic anatomy in the United States and internationally. It offers iFuse, a minimally invasive surgical implant system to address sacroiliac joint dysfunction and degeneration, adult deformity, and pelvic ring traumatic fract...
More about SIBN
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.